Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO00705) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Norverapamil
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Preclinical/Patented Drug
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=104972"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Cytochrome P450 3A5 (CYP3A5) | DME Info | Homo sapiens | [1] | |||
| Xenobiotics-DME Activity Data | ||||||
| Xenobiotics-DME Activity Data | Cytochrome P450 3A5 (CYP3A5) | DME Info | Ki = 4.53 microM | [1] | ||
| References | ||||||
| 1 | Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity. Curr Drug Metab. 2005 Oct;6(5):413-54. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.